Doug Constable Joins Life Science Outsourcing as CEO to Drive Growth

Life Science Outsourcing Welcomes Doug Constable as New CEO

Life Science Outsourcing, Inc. (LSO), a prominent contract manufacturer known for its services to medical device and life science sectors, has recently announced the appointment of Doug Constable as its new Chief Executive Officer. With over 30 years of extensive leadership experience in the MedTech industry, Constable is expected to drive the company's next phase of growth under the guidance of PPC Enterprises, LLC.

A New Chapter Begins

Doug Constable comes to LSO with an impressive background, having most recently served as the Chief Executive Officer of Clayens North America, a company specializing in precision plastic and metal solutions. His strategic leadership in expanding the company into the U.S. and Mexican markets showcases his capabilities in navigating complex business environments. Moreover, Constable has a track record of successfully guiding more than 40 strategic transactions throughout his career, which positions him well to lead LSO towards further achievements.

LSO is optimistic about its future as it continues to diversify its market reach and enhance its service capabilities. Earlier this year, the company strengthened its position by acquiring key manufacturing assets from a leading global player in precision microfluidics and diagnostic manufacturing. This acquisition builds upon the strategic purchase of J-Pac Medical from 2023, indicating LSO's commitment to expanding its offerings in the medical device sector.

Vision for the Future

Asif Zaman, Partner and Head of Healthcare Services at PPC, expressed enthusiasm for Constable’s appointment, stating, "Doug understands the opportunities ahead for LSO and the customers we serve. His leadership will be crucial in accelerating our growth and reinforcing LSO's reputation as a trusted partner for innovative medical device and life science companies worldwide."

Doug Constable shared his excitement about joining LSO, saying, "I am honored to step into this new role and energized by the opportunities that lie ahead. The company is well-positioned for rapid growth and ongoing success, and I consider it a privilege to lead us into this next chapter. LSO has built a strong reputation for quality and excellence in medical device contract manufacturing, which I am committed to maintaining as we expand our capabilities and reach."

Commitment to Operational Excellence

John Morgan, Operating Partner at PPC, highlighted Doug's significant history of achieving operational excellence and driving substantial business performance. He remarked, "His experience in managing and scaling complex manufacturing organizations will be invaluable as LSO continues to evolve and broaden its capabilities within the medical device and life science markets."

About Life Science Outsourcing

Founded as a full-service medical device contract manufacturer, LSO holds FDA registration and ISO 13485 certification. The company offers a wide range of services, including medical device manufacturing, cleanroom assembly, packaging and sterilization, as well as distribution and quality incubator services. With operational facilities in Brea, California; Somersworth, New Hampshire; and Costa Rica, LSO serves a diverse clientele within the healthcare sector.

About PPC Enterprises

PPC Enterprises LLC, based in New York, is a private equity fund established by experienced professionals from Kohlberg Kravis Roberts & Co. The fund invests in specific industries, focusing on sectors such as Healthcare Services, Business and Financial Services, and Industrial Services.

For further information about Life Science Outsourcing, visit www.lso-inc.com. For more details regarding PPC Enterprises, please check out www.ppcenterprises.com.